Atara Biotherapeutics (ATRA) Revenue & Revenue Breakdown
Atara Biotherapeutics Revenue Highlights
Latest Revenue (Y)
$8.57M
Latest Revenue (Q)
$28.64M
Atara Biotherapeutics Revenue by Period
Atara Biotherapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $8.57M | -86.51% |
| 2022-12-31 | $63.57M | 212.55% |
| 2021-12-31 | $20.34M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | - |
Atara Biotherapeutics generated $8.57M in revenue during NA 2023, up -86.51% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Atara Biotherapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $28.64M | 4.69% |
| 2024-03-31 | $27.36M | 543.39% |
| 2023-12-31 | $4.25M | 98.88% |
| 2023-09-30 | $2.14M | 123.41% |
| 2023-06-30 | $957.00K | -21.94% |
| 2023-03-31 | $1.23M | 454.75% |
| 2022-12-31 | $221.00K | -95.04% |
| 2022-09-30 | $4.46M | -91.36% |
| 2022-06-30 | $51.58M | 605.21% |
| 2022-03-31 | $7.31M | -3.10% |
| 2021-12-31 | $7.55M | 40.56% |
| 2021-09-30 | $5.37M | 38.76% |
| 2021-06-30 | $3.87M | 8.95% |
| 2021-03-31 | $3.55M | -99.01% |
| 2020-12-31 | $358.19M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | - |
Atara Biotherapeutics generated $28.64M in revenue during Q2 2024, up 4.69% compared to the previous quarter, and up 2336.05% compared to the same period a year ago.
Atara Biotherapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals | $366.28M | $179.14M |
| KPTI | Karyopharm Therapeutics | $146.03M | $42.79M |
| HRTX | Heron Therapeutics | $127.04M | $46.54M |
| RCUS | Arcus Biosciences | $117.00M | $39.00M |
| FATE | Fate Therapeutics | $63.53M | $6.77M |
| CRBU | Caribou Biosciences | $34.48M | $3.46M |
| VECT | VectivBio | $27.34M | $676.00K |
| TCRX | TScan Therapeutics | $21.05M | - |
| HOOK | HOOKIPA Pharma | $20.13M | - |
| ITOS | iTeos Therapeutics | $12.60M | - |
| MREO | Mereo BioPharma Group | $10.00M | - |
| ATRA | Atara Biotherapeutics | $8.57M | $28.64M |
| BTAI | BioXcel Therapeutics | $1.38M | $1.10M |
| ALLO | Allogene Therapeutics | $95.00K | $22.00K |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| ABOS | Acumen Pharmaceuticals | - | - |
| SANA | Sana Bio | - | - |
ATRA Revenue FAQ
What is Atara Biotherapeutics’s yearly revenue?
Atara Biotherapeutics's yearly revenue for 2023 was $8.57M, representing a decrease of -86.51% compared to 2022. The company's yearly revenue for 2022 was $63.57M, representing an increase of 212.55% compared to 2021. ATRA's yearly revenue for 2021 was $20.34M, representing an increase of 100.00% compared to 2020.
What is Atara Biotherapeutics’s quarterly revenue?
Atara Biotherapeutics's quarterly revenue for Q2 2024 was $28.64M, a 4.69% increase from the previous quarter (Q1 2024), and a 2892.69% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $27.36M, a 543.39% increase from the previous quarter (Q4 2023), and a 2131.40% increase year-over-year (Q1 2023). ATRA's quarterly revenue for Q4 2023 was $4.25M, a 98.88% increase from the previous quarter (Q3 2023), and a 1823.98% increase year-over-year (Q4 2022).
What is Atara Biotherapeutics’s revenue growth rate?
Atara Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was -57.85%, and for the last 5 years (2019-2023) was 0%.